Article
Novel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding
5 Jun 2012
Abstract excerpt
BACKGROUND: Atypical hemolytic uremic syndrome (aHUS) is associated with mutations affecting complement proteins and regulators and with autoantibodies against complement factor H (CFH). Approximately half of the aHUS patients progress to end-stage renal disease. DNA analysis of the risk factor genes is important for prognosis of aHUS recurrence after renal transplantation. METHODS: Mutational screening of C3...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
